Todd Pitts, MD
Orthopaedic Surgery · Lehi, UTNPI 1780979575
Payments from drug & device makers
Across 153 payments — averaging $71.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$2K
- Stryker$2K
- Smith+Nephew$2K
- Active Medical, LLC$2K
- Arthrex$884
- Pacira Therapeutics, Inc.$353
- plus $1K from 28 others
What the payments were for
- Travel & lodging$3,65133%
- Food & beverage$3,65233%
- Education$3,60833%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 3 | $2,425 |
| Stryker | 24 | $2,390 |
| Smith+Nephew | 29 | $2,116 |
| Active Medical, LLC | 2 | $1,547 |
| Arthrex | 6 | $884 |
| Pacira Therapeutics, Inc. | 37 | $353 |
| Johnson & Johnson | 5 | $166 |
| Amgen | 10 | $155 |
| Zimmer Biomet | 4 | $119 |
| Heron Therapeutics, Inc. | 1 | $73 |
| Globus Medical | 2 | $71 |
| Medacta USA, Inc. | 1 | $59 |
| Medtronic | 2 | $44 |
| Nalu Medical, Inc. | 1 | $40 |
| Orthofix Medical, Inc. | 5 | $40 |
| Bioventus LLC | 1 | $39 |
| Nevro Corp. | 1 | $35 |
| Think Surgical, Inc. | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 2 | $28 |
| Endo Pharmaceuticals Inc. | 2 | $28 |
| Davol Inc. | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Microport Orthopedics Inc | 1 | $23 |
| Trevena, Inc. | 1 | $22 |
| Si-bone, Inc. | 1 | $22 |
| Endo USA, Inc. | 1 | $21 |
| Spinal Simplicity, LLC | 1 | $20 |
| FX Shoulder Solutions, Inc | 1 | $19 |
| ERMI LLC | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Baudax Bio Inc. | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Arthrosurface Incorporated | 1 | $11 |
| Orthosensor Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,619
- Birmingham Hip Resurfacing$422
- REDAPT Revision Hip System$422
- Journey II XR$225
- Journey II BCS$201
- HOFFMANN$162
- TRIATHLON$104
- ACCOLADE$104
How this compares
$10,911 in reported general payments places this provider in the 65th percentile of 221 orthopaedic surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 43 | $306 |
| Meloxicam | 16 | $96 |
| Methocarbamol | 13 | $93 |
| Tramadol Hcl | 16 | $67 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Lehi
- Hugh WestMurray$14.2M
- Aaron HofmannSalt Lake City$10.7M
- Armen KhachatryanWest Jordan$3.9M
- Thomas CaltonWashington Terrace$3.5M
- Jeremy GilillandSalt Lake City$3.3M
- Robert TashjianSalt Lake City$3M
- Joshua HickmanBountiful$2.7M
- Jeffrey JacksonSalt Lake City$2.3M
- Peter StevensSlc$2.1M
- Brandon LawrenceSalt Lake City$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.